Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Lett Appl Microbiol ; 72(3): 292-298, 2021 Mar.
Article in English | MEDLINE | ID: mdl-32790923

ABSTRACT

Dermatophytoses are infections that affect keratinized tissues. Their main etiologic agents are fungi of the genera Microsporum and Trichophyton. The emergence of resistant fungi and the clinical relevance of dermatophytosis have encouraged studies that aim to increase the arsenal of drugs or act on mechanisms that confer multiple drug resistance. This study investigated the modulating activity of terbinafine promoted by dihydrojasmone and terpinolene against Microsporum canis LM 216, Trichophyton interdigitale H6 and T. interdigitale Δmdr2. The minimum inhibitory concentration (MIC) of test drugs was determined by broth microdilution. The effect of the drugs tested on plasma membrane functionality was analysed. Terbinafine MIC was determined in sub-inhibitory concentrations of monoterpenes. Finally, it was performed an association study with terbinafine and monoterpenes. Dihydrojasmone presented lower MIC values than terpinolene. All fungi were sensitive to terbinafine, starting at 1 µg ml-1 . All tested drugs increased K+ release (P < 0·05), affecting the functionality of the plasma membrane. Dihydrojasmone modulated the sensitivity of all strains against terbinafine, and terpinolene modulated the sensitivity of M. canis LM 216 and T. interdigitale Δmdr2. The monoterpenes and terbinafine drug associations presented synergism. In conclusion, the results suggest that the dihydrojasmone and terpinolene are promising antifungal agents that potentiate the antifungal activity of terbinafine against dermatophytes.


Subject(s)
Antifungal Agents/pharmacology , Arthrodermataceae/drug effects , Cyclohexane Monoterpenes/pharmacology , Dermatomycoses/drug therapy , Microsporum/drug effects , Terbinafine/pharmacology , Humans , Microbial Sensitivity Tests , Monoterpenes/pharmacology
2.
Fitoterapia ; 76(2): 247-9, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15752642

ABSTRACT

The antifungal activity of Eugenia cariophyllata essential oil and eugenol, its major constituent, on fungal strains isolated from onychomycosis was evaluated. The natural products presented prominent antifungal action with MIC of 1% and 4%, respectively.


Subject(s)
Antifungal Agents/pharmacology , Eugenol/pharmacology , Mitosporic Fungi/drug effects , Phytotherapy , Plant Oils/pharmacology , Syzygium , Antifungal Agents/administration & dosage , Antifungal Agents/therapeutic use , Eugenol/administration & dosage , Eugenol/therapeutic use , Humans , Microbial Sensitivity Tests , Onychomycosis/microbiology , Plant Oils/administration & dosage , Plant Oils/therapeutic use
3.
Thyroid ; 10(9): 833-5, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11041463

ABSTRACT

We report an uncommon case of a 20-year-old man, who noted a painless, growing mass in his neck, which appeared in a weekend, associated with moderate dysphagia and weakness. Laboratory examination revealed an elevated serum thyrotropin of 25 mU/L, normal serum triiodothyronine and thyroxine levels, and high titers of antithyroglobulin and antithyroid peroxidase antibodies. The neck lesion showed a depressed iodine uptake in the left thyroid lobe, which had an asymmetrical pseudocystic pattern associated with poor vascularization in the ultrasound scan. Cytologic examination showed a lymphocyte thyroiditis in association with lymphoma of large cell arising from mucosa-associated lymphoid tissue (MALT-lymphoma or maltoma). The patient underwent a left thyroid lobectomy while being treated with levothyroxine for Hashimoto's thyroiditis, and the surgical treatment was further complemented with chemotherapy using fludarabine. The histologic examination confirmed the cytologic findings and the immunohistochemistry showed a B-cell type maltoma. Additional investigation provided no evidence of disease in other tissues. The clinical course has been favorable in the first 2 years of follow-up, with no evidence of local or systemic recurrence of the disease.


Subject(s)
Lymphoma, B-Cell, Marginal Zone/complications , Thyroid Neoplasms/complications , Thyroiditis, Autoimmune/complications , Vidarabine/analogs & derivatives , Adult , Antineoplastic Agents/therapeutic use , Autoantibodies/blood , Humans , Iodide Peroxidase/immunology , Lymphoma, B-Cell, Marginal Zone/diagnosis , Lymphoma, B-Cell, Marginal Zone/therapy , Male , Thyroglobulin/immunology , Thyroid Neoplasms/diagnosis , Thyroid Neoplasms/therapy , Thyroidectomy , Thyroiditis, Autoimmune/diagnosis , Thyroiditis, Autoimmune/drug therapy , Thyrotropin/blood , Thyroxine/blood , Thyroxine/therapeutic use , Triiodothyronine/blood , Vidarabine/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...